American Shared Hospital Services (NYSE American: AMS) announced today that it will release its first quarter 2026 financial results before the market opens on May 14, 2026, and hold a conference call at 12:00 PM ET the same day to discuss the results. The call will be led by the company's executive leadership, including Executive Chairman Ray Stachowiak, and will cover financial performance, operational highlights, and strategic initiatives in the cancer treatment services sector.
The conference call is accessible to domestic callers at 1-844-413-3972 and international callers at 1-412-317-5776, with participants asked to dial in at least ten minutes prior to the start. A simultaneous webcast will be available through the company's website at www.ashs.com or directly via this link. For those unable to attend live, a replay will be available from May 14 through May 21, 2026, by dialing 1-855-669-9658 or 1-412-317-0088, using access code 6753554. The webcast replay will also be posted on the company's website.
American Shared Hospital Services is a leading provider of turnkey solutions to cancer treatment centers, health systems, and cancer networks across North and South America. The company specializes in stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its equipment leasing and direct patient care segments. By partnering with health systems, AMS shares in capital investment costs and profitability based on ownership interests, enabling integrated cancer care in local community settings.
The upcoming financial results and conference call are important for investors and industry observers as they provide a snapshot of the company's performance in the first quarter of 2026, which may reflect trends in the adoption of advanced radiation therapy technologies, such as Gamma Knife and proton therapy. The call will also offer insights into the company's operational strategy and market expansion, particularly in the context of evolving reimbursement rates and healthcare delivery models.
Forward-looking statements in the press release highlight risks and uncertainties, including economic conditions, compliance with debt covenants, variability of financial results between quarters, and changes in CMS reimbursement rates. These factors could affect the company's financial condition and future plans, as detailed in its filings with the Securities and Exchange Commission, such as the Annual Report on Form 10-K for the year ended December 31, 2025.
Investors and analysts are encouraged to participate in the call to gain a deeper understanding of AMS's financial health and strategic direction. The company's continued focus on expanding its cancer treatment services positions it as a key player in the oncology sector, making this earnings release a significant event for stakeholders tracking advancements in cancer care technology and service delivery.
